as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
5.38%
Downside
3.46%
Upside
52 Week's Low
52 Week's High
65.00%
Downside
74.51%
Upside
Check Editas Medicine Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$263.6M
EPS (TTM)
-1.9743
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.58
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
-113.8M
Revenue (TTM)
46.4M
Profit Margin
0.00%
Return On Equity TTM
-211.37%
Track how Editas Medicine Inc. P/E has moved over time to understand its valuation trends.
Editas Medicine Inc. in the last 5 years
Lowest (-26.25x)
March 31, 2021
Today (-1.58x)
November 14, 2025
Industry (-0.81x)
November 14, 2025
Highest (-0.48x)
March 31, 2025
Today’s Price to Earnings Ratio: -1.58x
Compare market cap, revenue, PE, and other key metrics of Editas Medicine Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $263.6M | -91.31% | -1.58 | 0.00% | |
| BUY | $59.8B | 235.01% | 1414.81 | 1.36% | |
| NA | $40.9B | NA | 712.21 | 1.38% | |
| BUY | $110.2B | 92.67% | 30.58 | 31.35% | |
| BUY | $71.6B | 22.7% | 16.34 | 32.13% |
The Editas Medicine Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Editas Medicine Inc. investment value today
Current value as on today
₹99,057
Returns
Returns from Editas Medicine Inc. Stock
Dollar Returns*
₹5,194 (+5.19%)
Based on 24 analysts
54.17%
Buy
41.67%
Hold
4.17%
Sell
Based on 24 analysts, 54.17% of analysts recommend a 'BUY' rating for Editas Medicine Inc.. Average target price of $4
Get share price movements and forecasts by analysts on Editas Medicine Inc..
What analysts predicted
35%UPSIDE
Target Price
$4
Current Price
$2.6
Analyzed by
24 Analysts
Target
$4.00
Editas Medicine Inc. target price $4, a slight upside of 35% compared to current price of $2.6. According to 24 analysts rating.
Search interest for Editas Medicine Inc. Stock has increased by 57% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:57% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 3.57M → 7.54M (in $), with an average increase of 52.6% per quarter
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -76.08M → -25.11M (in $), with an average increase of 77.4% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 94.7% return, outperforming this stock by 99.2%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.3% return, outperforming this stock by 157.8%
Price Dip
![]()
In the last 1 month, EDIT stock has moved down by -37.4%
| Organisation | Editas Medicine Inc. |
| Headquarters | 11 Hurley Street, Cambridge, MA, United States, 02141 |
| Industry | Health Technology |
| CEO | Dr. Gilmore O'Neill M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Gilmore O'Neill M.D. | President, CEO & Director |
Ms. Amy Parison | Senior VP & CFO |
Ms. Brieana Buckley | Senior Vice President of Development and Program Leadership |
Dr. Feng Zhang Ph.D. | Co-Founder & Scientific Advisory Board Member |
Dr. George McDonald Church Ph.D. | Co-Founder & Scientific Advisory Board Member |
Mr. Gregory Whitehead | Executive VP and Chief Technical & Quality Officer |
Dr. Linda C. Burkly Ph.D. | Executive VP & Chief Scientific Officer |
Cristi Barnett | Senior VP of Corporate Communications & Investor Relations |
Mr. Damien Grierson J.D. | Senior VP, General Counsel & Corporate Secretary |
Mr. Frank Panaccio | Senior VP & Chief Business Officer |
Editas Medicine Inc. share price today is $2.6 as on at the close of the market. Editas Medicine Inc. share today touched a day high of $2.69 and a low of $2.46.
Editas Medicine Inc. share touched a 52 week high of $4.54 on and a 52 week low of $0.91 on . Editas Medicine Inc. stock price today i.e. is closed at $2.6,which is 42.70% down from its 52 week high and 185.68% up from its 52 week low.
Editas Medicine Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Editas Medicine Inc. (EDIT) shares with as little as ₹88.7 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.00 in Editas Medicine Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Editas Medicine Inc. share’s latest price of $2.6 as on November 15, 2025 at 2:29 am IST, you will get 3.8462 shares of Editas Medicine Inc.. Learn more about
fractional shares .
Editas Medicine Inc. stock has given -91.31% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?